[ORGANIZATION]
Scanntech
Featured in 6 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
343 clusters · 1318 sources · last updated
Latest: FDA issues warning for GLP-1 drugs over vision loss risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
Brazil plans semaglutide integration into SUS
12 clusters · 172 sources · last updated
Latest: Anvisa regulates weight-loss medications and seizes irregular supplements
The Brazilian Ministry of Health is progressing with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). On September 24, 2026, the Ministry submitted a formal request to
Also covered in
-
Partners Group and Prosus execute strategic investment shifts
[BUSINESS] · 2 sources ·
-
Coca-Cola to launch sugar-free, caffeine-free version in Brazil
[BUSINESS] · 3 sources ·